ArticleJournal of chemical theory and computation2025
RLDOCKScore: A Scoring Function for RNA-Ligand Docking and Small Molecule Virtual Screening.
Article in Journal of chemical theory and computation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Docking-based virtual screening: Past, present, and future.Biophysical journal · 2026Review
- Machine Learning for RNA-Targeting Drug Design.Journal of chemical information and modeling · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Virtual screening of large compound libraries against specific RNAs offers a promising and cost-effective approach for identifying novel lead compounds. Developing a reliable scoring function for RNA-ligand interactions is crucial for effective computational drug screening. However, current RNA-ligand scoring functions are primarily designed to predict native binding poses for given RNA-ligand pairs and have not been thoroughly evaluated for their virtual screening capabilities. Here, by leveraging more accurate descriptions of stacking, solvation, conformational flexibility, and other key effects, we developed RLDOCKScore, an enhanced scoring function optimized for both pose prediction and virtual screening. RLDOCKScore demonstrates overall better performance compared with other tested scoring functions, effectively balancing pose prediction accuracy with virtual screening capabilities. In pose prediction evaluations using 122 RNA-ligand complexes, RLDOCKScore outperforms all of the tested scoring functions except SPRank. For virtual screening applications, RLDOCKScore showed overall better performance than other methods when tested against the HIV-1 TAR ensemble and four riboswitches from the ROBIN benchmark set, with the best top-2% enrichment factor and the AUC value reaching 25.0 and 0.86, respectively, for the HIV-1 TAR ensemble. These results establish RLDOCKScore as a valuable new method for computational drug discovery applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.